Abstract 37: IL-4 drives CART cell exhaustion in a CD4 independent manner

作者
Carli M. Stewart,Elizabeth L. Siegler,Truc Huynh,Reona Leo Sakemura,Brooke L. Kimball,Long Mai,Kun Yun,James H. Girsch,Jennifer Meyer Feigin,Omar Gutierrez Ruiz,Makena Rodriguez,Ekene J. Ogbodo,İsmail Can,Claudia Manriquez Roman,Olivia L. Sirpilla,Hong Xia,Jenny J Kim,Justin A. Budka,Mike Mattie,Nathalie Scholler
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 37-37
标识
DOI:10.1158/1538-7445.am2024-37
摘要

Abstract While chimeric antigen receptor T (CART) cell therapy has shown remarkable success, the development of exhaustion limits durable response. We identified a role for interleukin (IL)-4 in the development of CART cell exhaustion through three independent approaches including: 1) a genome-wide CRISPR knockout screen using healthy donor CART cells in an in vitro model for exhaustion, 2) RNA and ATAC sequencing on freshly produced and chronically stimulated healthy donor CART cells, and 3) RNA and ATAC sequencing on pre-infusion CART cell products from responders and non-responders in the Zuma-1 clinical trial that led to the FDA approval of axi-cel. Further, in vitro validation studies revealed that CD19 directed CART (CART19) cells chronically stimulated in the presence of human recombinant IL-4 (hrIL-4) displayed signs of exhaustion such as 1) decreased proliferation (p = 0.01), 2) increased coexpression of inhibitory receptors (p = 0.01), and 3) decreased production of IL-2 and interferon (IFN)-γ (p= 0.02, p = 0.002). Encouragingly, CART19 cells combined with an IL-4 monoclonal antibody improved antitumor activity (p = 0.045) and expansion (p = 0.01) while also decreasing the co-expression of inhibitory receptors (p = 0.02) in a mantle cell lymphoma xenograft mouse model. Building on these results, we asked if IL-4 driven exhaustion results from a direct impact of IL-4 on CART cells. To test this, we used a tumor-free assay where CART19 cells were chronically stimulated with CD19 beads in the presence of hrIL-4 or diluent. CART cells treated with hrIL-4 displayed an exhausted phenotype characterized by increased co-expression of inhibitory receptors (p = 0.04) and decreased production of IL-2 (p = 0.01). Next, we asked if IL-4 driven CART cell exhaustion is dependent on the costimulatory domain. We tested the impact of IL-4 on both CD28ζ and 41BBζ costimulated CART19 cells. Similar to our previous studies with CART19-28ζ cells, chronic stimulation of CART19-BBζ cells in the presence of hrIL-4 enhanced the exhausted phenotype as seen by increased co-expression of inhibitory receptors (p = 0.04) and decreased production of IL-2 and IFN-γ (p = 0.08 and p = 0.007). Finally, we asked if IL-4 induces exhaustion independently of its classic role in Th2 polarization of CD4 CART cells. Following CART production, we isolated CD8 cells and chronically stimulated them in the presence of hrIL-4 or diluent. CD8 CART cells treated with hrIL-4 displayed an enhanced exhausted profile as seen by 1) decreased proliferative ability (p < 0.0001), 2) increased co-expression of inhibitory receptors (p = 0.01), and 3) decreased production of IL-2 and IFN-γ (p < 0.0001, p = 0.004). Together, our data indicates a novel role for IL-4 in the development of CART cell exhaustion that is independent of tumor cells, costimulatory domain, and CD4 cells. As such, we believe IL-4 neutralization may be a widely applicable and actionable approach to improve the durable response to CART cell therapy. Citation Format: Carli M. Stewart, Elizabeth L. Siegler, Truc N. Huynh, R. Leo Sakemura, Brooke Kimball, Long Mai, Kun Yun, James H. Girsch, Jennifer Feigin, Omar Gutierrez Ruiz, Makena Rodriguez, Ekene Ogbodo, Ismail Can, Claudia Manriquez Roman, Olivia Sirpilla, Hong Xia, Jenny Kim, Justin Budka, Mike Mattie, Nathalie Scholler, Simone Filosto, Saad S. Kenderian. IL-4 drives CART cell exhaustion in a CD4 independent manner [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 37.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Sheep完成签到,获得积分10
1秒前
cmh发布了新的文献求助10
1秒前
liquidwy完成签到,获得积分10
1秒前
123发布了新的文献求助10
1秒前
1秒前
想上985完成签到,获得积分10
2秒前
2秒前
clyhg完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
wuhu发布了新的文献求助10
2秒前
3秒前
活力的钢笔完成签到,获得积分10
3秒前
3秒前
我爱科研完成签到,获得积分10
4秒前
共享精神的应助被weddcf采纳,获得10
4秒前
蔓越莓发布了新的文献求助10
4秒前
cloudss发布了新的文献求助10
5秒前
5秒前
sevenseven完成签到,获得积分10
5秒前
5秒前
zhouzhou完成签到 ,获得积分10
5秒前
甜美冰旋完成签到,获得积分10
5秒前
斯文败类的应助被FeCl采纳,获得10
6秒前
nannan完成签到,获得积分10
6秒前
现代的东蒽完成签到,获得积分10
6秒前
脑洞疼的应助被Duxize采纳,获得10
6秒前
爆米花的应助被1820采纳,获得10
7秒前
start发布了新的文献求助10
7秒前
人生如梦完成签到,获得积分10
7秒前
海猫食堂完成签到,获得积分10
8秒前
4XXXX完成签到,获得积分10
8秒前
8秒前
9秒前
9秒前
微笑发布了新的文献求助10
9秒前
AnZeng完成签到,获得积分10
9秒前
天天快乐的应助被xdlongchem采纳,获得10
9秒前
亳亳发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180617
求助须知:如何正确求助?哪些是违规求助? 9570702
关于积分的说明 21813868
捐赠科研通 7776860
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557571
邀请新用户注册赠送积分活动 2479253